Company Zhejiang Ausun Pharmaceutical Co., Ltd.

Equities

603229

CNE100002XK2

Pharmaceuticals

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
10.2 CNY +0.39% Intraday chart for Zhejiang Ausun Pharmaceutical Co., Ltd. -8.52% -22.79%

Business Summary

Zhejiang Ausun Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of specialty bulk pharmaceutical chemicals (BPCs) and pharmaceutical intermediates. The Company's main products include bimatoprost, latanoprost, latanoprostene bunod, entecavir, selectfluor and other intermediates. The Company is also involved in the provision of customized production, as well as research and development services to customers through its subsidiaries.

Number of employees: 1,129

Sales per Business

CNY in Million2021Weight2022Weight Delta
Cardiovascular and Cerebrovascular
25.0 %
34 5.9 % 191 25.0 % +468.48%
Liver Diseases
23.6 %
157 27.6 % 180 23.6 % +14.85%
Nervous System
16.1 %
90 15.9 % 123 16.1 % +36.08%
Antibacterial
11.0 %
115 20.1 % 84 11.0 % -26.94%
Gout
9.4 %
46 8.1 % 72 9.4 % +54.76%
Other
7.2 %
55 9.7 % 55 7.2 % -0.45%
Technical Services
4.2 %
33 5.7 % 32 4.2 % -2.62%
Prostaglandin
2.5 %
14 2.5 % 19 2.5 % +35.50%
Respiratory System
0.5 %
10 1.8 % 4 0.5 % -60.19%
Anti-tumor
0.3 %
15 2.6 % 3 0.3 % -82.63%
High-end Fluorine
0.3 %
1 0.2 % 2 0.3 % +137.25%

Sales per region

CNY in Million2021Weight2022Weight Delta
International
57.3 %
306 53.7 % 438 57.3 % +43.36%
China
42.7 %
264 46.3 % 326 42.7 % +23.59%

Managers

Managers TitleAgeSince
Chief Executive Officer 53 14-12-14
Director of Finance/CFO 57 21-11-01
Director/Board Member 47 14-12-13
Investor Relations Contact - -
Corporate Secretary 43 21-12-24
Corporate Officer/Principal 62 20-07-14

Members of the board

Members of the board TitleAgeSince
Director/Board Member 44 15-01-07
Chief Executive Officer 53 14-12-14
Founder 55 14-12-13
Director/Board Member 47 14-12-13
Director/Board Member 49 14-12-13
Director/Board Member 42 14-12-14
Director/Board Member 56 17-12-12
Director/Board Member 37 12-12-31
Director/Board Member 51 20-12-12
Director/Board Member 37 12-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 593,069,389 237,411,769 ( 40.03 %) 0 40.03 %

Shareholders

NameEquities%Valuation
300,309,787 50.64 % 451 M ¥
16,536,929 2.788 % 25 M ¥
LAV Management Co., Ltd.
1.158 %
6,867,668 1.158 % 10 M ¥
Bing Liu
1.123 %
6,662,326 1.123 % 10 M ¥
2,756,074 0.4647 % 4 M ¥
Yinhua Fund Management Co., Ltd.
0.4009 %
2,377,889 0.4009 % 4 M ¥
GF Fund Management Co., Ltd.
0.1964 %
1,164,934 0.1964 % 2 M ¥
Penghua Fund Management Co., Ltd.
0.1805 %
1,070,720 0.1805 % 2 M ¥
Caitong Fund Management Co., Ltd.
0.1430 %
847,913 0.1430 % 1 M ¥
China Merchants Fund Management Co., Ltd.
0.1039 %
616,115 0.1039 % 925 898 ¥

Company contact information

Zhejiang Ausun Pharmaceutical Co., Ltd.

5 Donghai Fourth Avenue Linhai Park

317016, Taizhou

+

http://www.ausunpharm.com
address Zhejiang Ausun Pharmaceutical Co., Ltd.(603229)

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.2
Average target price
-
Consensus

Annual profits - Rate of surprise